2seventy bio (TSVT) Price & Analysis

Compare

276 Followers

TSVT Stock Chart & Stats

Day’s Range― - ―

52-Week Range$2.29 - $5.30

Previous CloseN/A

Volume53.84K

Average Volume (3M)1.05M

Market Cap

$266.15M

Enterprise ValueN/A

Total Cash (Recent Filing)$174.75M

Total Debt (Recent Filing)$243.72M

Price to Earnings (P/E)―

Beta1.42

Next Earnings

Aug 06, 2025

EPS Estimate

-0.15

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.01

Shares Outstanding53,229,790

10 Day Avg. Volume955,203

30 Day Avg. Volume1,051,216

Financial Highlights & Ratios

PEG Ratio-0.11

Price to Book (P/B)1.23

Price to Sales (P/S)0.00

P/FCF Ratio-3.02

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$5.00

Price Target Upside0.00%

Rating ConsensusHold

Number of Analyst Covering2

2seventy bio News

PremiumCompany Announcements

2Seventy Bio Reports Strong Q1 2025 Earnings

18d ago

TSVT

PremiumCompany Announcements

2seventy bio Completes Merger, Delists from Nasdaq

20d ago

TSVT

PremiumCompany Announcements

2seventy bio Reports 2024 Earnings Amid BMS Merger

2M ago

TSVT

PremiumThe Fly

2seventy Bio reports Q4 EPS (37c) vs ($1.11) last year

2M ago

TSVT

PremiumPre-Earnings

Is TSVT a Buy, Before Earnings?

2M ago

TSVT

PremiumCompany Announcements

2seventy bio Delays Yearly Report Filing

3M ago

TSVT

PremiumThe Fly

2seventy Bio price target lowered to $5 from $6 at Morgan Stanley

3M ago

BMY

TSVT

PremiumRatings

Hold Rating Amidst Favorable Acquisition Terms and Competitive Pressures for 2seventy bio

3M ago

TSVT

See All TSVT News

See All News >

Bulls Say, Bears Say

Bulls Say

Acquisition PremiumThe acquisition of 2Seventy Bio by Bristol-Myers Squibb implies an 80% premium to the previous closing price, boosting investor confidence.

Cash Position2Seventy Bio ended the quarter with $192 million in cash, providing a solid financial base and extending its cash runway beyond 2027.

Bears Say

Market UncertaintyMarket uncertainty persists with the expected launch of a third BCMA CAR-T by competitors, posing a threat to Abecma's market position.

Revenue Challenges2Seventy's top-line revenue fell short of expectations, highlighting challenges in capturing anticipated profits from Abecma.

Financials

Income Statement >

Options Prices

Detailed Option Prices >

Ownership Overview

10.07% Insiders

10.60% Mutual Funds

<0.01% Other Institutional Investors

84.13% Public Companies and

Individual Investors

Detailed Ownership Overview >

TSVT FAQ

What was 2Seventy Bio, Inc.’s price range in the past 12 months?

2Seventy Bio, Inc. lowest stock price was $2.29 and its highest was $5.30 in the past 12 months.

What is 2Seventy Bio, Inc.’s market cap?

2Seventy Bio, Inc.’s market cap is $266.15M.

When is 2Seventy Bio, Inc.’s upcoming earnings report date?

2Seventy Bio, Inc.’s upcoming earnings report date is Aug 06, 2025 which is in 65 days.

How were 2Seventy Bio, Inc.’s earnings last quarter?

2Seventy Bio, Inc. released its earnings results on May 07, 2025. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.17 by $0.18.

Is 2Seventy Bio, Inc. overvalued?

According to Wall Street analysts 2Seventy Bio, Inc.’s price is currently same. Get more investment ideas with TipRanks Premium

Does 2Seventy Bio, Inc. pay dividends?

2Seventy Bio, Inc. does not currently pay dividends.

What is 2Seventy Bio, Inc.’s EPS estimate?

2Seventy Bio, Inc.’s EPS estimate is -0.15.

How many shares outstanding does 2Seventy Bio, Inc. have?

2Seventy Bio, Inc. has 53,229,790 shares outstanding.

What happened to 2Seventy Bio, Inc.’s price movement after its last earnings report?

2Seventy Bio, Inc. reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.17. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of 2Seventy Bio, Inc.?

Currently, no hedge funds are holding shares in TSVT

2seventy bio Stock Smart Score

Underperform

Fundamentals

Return on Equity

-1.94%

Trailing 12-Months

Asset Growth

-6.07%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

2Seventy Bio, Inc.

2seventy bio (TSVT) is a biotechnology company focused on the development and commercialization of innovative cell therapies for the treatment of cancer. Operating in the biopharmaceutical sector, 2seventy bio is dedicated to advancing its pipeline of autologous and allogeneic therapies to improve the lives of patients with serious and life-threatening oncologic diseases.

TSVT Stock 12 Month Forecast

Average Price Target

$5.00

▲(0.00%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","6":"$6","2.25":"$2.25","3.5":"$3.5","4.75":"$4.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$5.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2.25,3.5,4.75,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Aug<br/>2024","9":"Nov<br/>2024","12":"Mar<br/>2025","25":"Mar<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.64,2.8215384615384616,3.0030769230769234,3.184615384615385,3.3661538461538463,3.5476923076923077,3.729230769230769,3.910769230769231,4.092307692307692,4.273846153846154,4.455384615384616,4.636923076923077,4.818461538461539,{"y":5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.64,2.8215384615384616,3.0030769230769234,3.184615384615385,3.3661538461538463,3.5476923076923077,3.729230769230769,3.910769230769231,4.092307692307692,4.273846153846154,4.455384615384616,4.636923076923077,4.818461538461539,{"y":5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.64,2.8215384615384616,3.0030769230769234,3.184615384615385,3.3661538461538463,3.5476923076923077,3.729230769230769,3.910769230769231,4.092307692307692,4.273846153846154,4.455384615384616,4.636923076923077,4.818461538461539,{"y":5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.19,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.64,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.79,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.6,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.23,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.05,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.28,"date":1722470400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.87,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.6,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.4,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.98,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.66,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.64,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >